Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.7M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 15 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 27 most recent Form 4 transactions.
| Sep 23 | TBPH | Theravance Biopharma, Inc. | DTOISS | 23,400 | — | — | -100.0% | Open the original filing on SEC.gov |
| Sep 23 | TBPH | Theravance Biopharma, Inc. | DTOISS | 76,875 | — | — | -100.0% | Open the original filing on SEC.gov |
| Sep 23 | TBPH | Theravance Biopharma, Inc. | DTOISS | 151,875 | — | — | -66.4% | Open the original filing on SEC.gov |
| Sep 23 | TBPH | Theravance Biopharma, Inc. | DTOISS | 1.4M | — | — | -85.8% | Open the original filing on SEC.gov |
| Aug 31 | JAZZ | Jazz Pharmaceuticals plc | FTAX | 14 | $244.64 | $3.4K | -0.1% | Open the original filing on SEC.gov |
| Aug 31 | JAZZ | Jazz Pharmaceuticals plc | FTAX | 1,692 | $241.39 | $408.4K | -15.2% | Open the original filing on SEC.gov |
| Aug 20 | TBPH | Theravance Biopharma, Inc. | FTAX | 20,034 | $16.95 | $339.6K | -1.2% | Open the original filing on SEC.gov |
| Aug 5 | JAZZ | Jazz Pharmaceuticals plc | AGRANT | 1,605 | — | — | +16.8% | Open the original filing on SEC.gov |
| May 22 | JAZZ | Jazz Pharmaceuticals plc | MEXER◆ | 3,415 | — | — | — | Open the original filing on SEC.gov |
| May 22 | JAZZ | Jazz Pharmaceuticals plc | SSELL | 2,741 | $241.57 | $662.1K | -22.3% | Open the original filing on SEC.gov |
| May 22 | JAZZ | Jazz Pharmaceuticals plc | MEXER | 3,415 | $138.08 | $471.5K | +38.4% | Open the original filing on SEC.gov |
| May 20 | TBPH | Theravance Biopharma, Inc. | FTAX | 20,038 | $16.55 | $331.6K | -1.2% | Open the original filing on SEC.gov |
| Apr 1 | TBPH | Theravance Biopharma, Inc. | AGRANT | 75,000 | — | — | +4.8% | Open the original filing on SEC.gov |
| Feb 20 | TBPH | Theravance Biopharma, Inc. | FTAX | 74,975 | $19.66 | $1.5M | -4.5% | Open the original filing on SEC.gov |
| Nov 20, 2025 | TBPH | Theravance Biopharma, Inc. | FTAX | 56,817 | $17.90 | $1M | -3.3% | Open the original filing on SEC.gov |
| Nov 19, 2025 | TBPH | Theravance Biopharma, Inc. | GGIFT | 9,900 | — | — | +73.3% | Open the original filing on SEC.gov |
| Nov 19, 2025 | TBPH | Theravance Biopharma, Inc. | GGIFT | 9,900 | — | — | -0.6% | Open the original filing on SEC.gov |
| Nov 18, 2025 | JAZZ | Jazz Pharmaceuticals plc | SSELL | 5,500 | $180.86 | $994.7K | -38.2% | Open the original filing on SEC.gov |
| Aug 20, 2025 | TBPH | Theravance Biopharma, Inc. | FTAX | 15,394 | $13.39 | $206.1K | -0.9% | Open the original filing on SEC.gov |
| Aug 8, 2025 | JAZZ | Jazz Pharmaceuticals plc | FTAX | 1,805 | $111.25 | $200.8K | -11.1% | Open the original filing on SEC.gov |
| Aug 7, 2025 | JAZZ | Jazz Pharmaceuticals plc | AGRANT | 3,507 | — | — | +27.6% | Open the original filing on SEC.gov |
| Jun 23, 2025 | TBPH | Theravance Biopharma, Inc. | GGIFT | 20,000 | — | — | -1.1% | Open the original filing on SEC.gov |
| Jun 13, 2025 | TBPH | Theravance Biopharma, Inc. | GGIFT | 9,600 | — | — | +246.2% | Open the original filing on SEC.gov |
| Jun 13, 2025 | TBPH | Theravance Biopharma, Inc. | GGIFT | 9,600 | — | — | -0.5% | Open the original filing on SEC.gov |
| May 20, 2025 | TBPH | Theravance Biopharma, Inc. | FTAX | 15,364 | $9.45 | $145.2K | -0.9% | Open the original filing on SEC.gov |